We Can Do Hard Things

Life-Saving Intel: Amanda's Breast Cancer Surgeon Dr. Lucy De La Cruz

October 21, 2025

Key Takeaways Copied to clipboard!

  • Awareness without actionable information leads to insanity, emphasizing the need to un-gatekeep vital health knowledge, especially during Breast Cancer Awareness Month. 
  • Breast density (Categories A, B, C, D) critically impacts mammogram effectiveness, with Category D (extremely dense) breasts requiring supplemental screening like an MRI due to a 4-6 times increased risk of cancer. 
  • Patients facing breast cancer surgery have multiple decision points—including lumpectomy vs. mastectomy, timing of reconstruction, and nipple preservation—that must be clearly presented as options rather than definitive answers based on a single doctor's bias. 
  • Direct-to-implant reconstruction, performed in a single surgery immediately following mastectomy, leads to better patient recovery and minimizes trauma compared to the traditional two-stage process involving tissue expanders, yet it is reportedly offered by only 11% of institutions. 
  • Nipple-sparing mastectomy should operate under the principle of 'innocent until proven guilty,' meaning the nipple should be preserved unless final pathology confirms cancer infiltration, rather than being preemptively removed based on imaging alone. 
  • Resensation techniques, which involve nerve grafting to reconnect the nipple to the chest wall nerve stump, should be considered a baseline standard of care to restore sensation, which is often lost after mastectomy and typically not disclosed to patients. 

Segments

Impact of Amanda’s Sharing
Copied to clipboard!
(00:00:10)
  • Key Takeaway: Amanda’s transparency regarding her breast cancer diagnosis has directly motivated listeners to advocate for their own health, leading to life-saving discoveries.
  • Summary: The podcast reflects on the profound impact of Amanda sharing her breast cancer experience, noting that listeners have been stopped to report that her story led them to discover their own cancers. The hosts emphasize that self-advocacy, spurred by shared information, is the most loving action one can take for loved ones. This segment celebrates being over a year out from the initial ‘hullabahoo’ (breast cancer event).
Awareness vs. Information
Copied to clipboard!
(00:02:50)
  • Key Takeaway: Breast Cancer Awareness Month should prioritize un-gated information dissemination over symbolic gestures like colored t-shirts.
  • Summary: Amanda advocates for doubling down on the ‘aware’ aspect of Breast Cancer Awareness Month by focusing on sharing actionable information. She asserts that awareness without a plan or information equals anxiety, highlighting that listeners used the shared knowledge to save their own lives. The segment features voicemails from listeners who discovered cancer because they pushed for screenings based on the podcast’s education.
Screening Gaps and Decision Points
Copied to clipboard!
(00:05:50)
  • Key Takeaway: Patients often face four different surgical solutions from four different surgeons because doctors present solutions based on their specialties rather than presenting all decision points.
  • Summary: The episode sets up the second part by promising to detail decision points that were not clearly presented as choices but rather as answers dictated by a specific doctor’s bias. The hosts stress that standard screenings fail 50% of women, necessitating self-advocacy to uncover potential issues early. Breast cancer is highly treatable and survivable when found early, with 70-80% of biopsies being negative.
Breast Density Education
Copied to clipboard!
(00:14:42)
  • Key Takeaway: Women with Category D (extremely dense) breasts have an independent 4-6 times increased risk for breast cancer, and mammograms miss 50-60% of cancers in dense tissue.
  • Summary: The four categories of breast density (A, B, C, D) determine mammogram visibility, as dense tissue appears white, masking white tumors. Category D breasts appear completely white on a mammogram, which is why Amanda’s cancer was missed just days before her mastectomy. Patients must ask their healthcare provider if they are Category C or D, and Category D patients must advocate for an MRI, as they face both higher risk and reduced detection capability from standard screening.
Advocacy for MRI Coverage
Copied to clipboard!
(00:20:21)
  • Key Takeaway: Doctors often do not automatically advocate for necessary MRIs for dense breasts due to cost/insurance hurdles, requiring patients to push for coverage using risk factors or even referencing educational materials.
  • Summary: It is illogical that patients must investigate why doctors aren’t advocating for necessary MRIs when dense breasts increase risk and obscure mammogram results. Insurance often covers an MRI if the patient advocates strongly, especially when combining dense tissue with family history to reach a certain risk threshold. A mini MRI option exists for around $500 out-of-pocket if full MRI insurance hurdles prove insurmountable.
Surgeon Mindset and Patient Choice
Copied to clipboard!
(00:38:35)
  • Key Takeaway: Informed consent requires presenting all oncologically safe alternatives, such as nipple-sparing mastectomy versus immediate reconstruction, to minimize patient trauma and decision fatigue.
  • Summary: Dr. De La Cruz emphasizes that her goal is to minimize the physical shock of surgery so patients still recognize themselves, acknowledging that decisions about nipples and reconstruction impact quality of life and sexuality. She prefers testing margins for nipple involvement after surgery rather than preemptively removing nipples if oncologically safe, as a second, smaller procedure is less traumatic than a primary loss. The surgeon-patient relationship is likened to a marriage where the patient must be educated and empowered to make the final choice.
Mastectomy vs. Lumpectomy Risks
Copied to clipboard!
(00:50:46)
  • Key Takeaway: Lumpectomy carries a compounding annual local recurrence risk of 0.5% to 1%, whereas mastectomy carries a lifetime local recurrence risk of up to 8%, though neither impacts overall survival as much as systemic treatment.
  • Summary: The decision between lumpectomy and mastectomy involves weighing the cumulative risk of recurrence against the peace of mind offered by removing all breast tissue. Patients choosing lumpectomy must accept ongoing monitoring via MRIs/mammograms, while mastectomy patients avoid this follow-up for breast tissue itself. Systemic treatments (chemo, hormone blockers) are crucial as they treat potential metastatic disease and directly impact long-term survival, making the medical oncologist’s role paramount.
Direct to Implant Rationale
Copied to clipboard!
(01:07:34)
  • Key Takeaway: Direct-to-implant reconstruction minimizes patient trauma by consolidating recovery into one surgery, unlike the multi-step process involving uncomfortable tissue expanders.
  • Summary: The traditional two-stage reconstruction involves mastectomy followed by recovery, then placement of temporary balloon-like expanders, leading to a second surgery for permanent implants. Dr. De La Cruz transitioned away from tissue expanders around 2017/2018 because patients experienced better recovery, avoided a second surgery, and saved on co-pays and time off work. This single-stage approach is preferred unless radiation is required, though even then, implants can be used before radiation.
Direct to Implant Availability
Copied to clipboard!
(01:15:23)
  • Key Takeaway: Lack of offering direct-to-implant reconstruction often reflects outdated practice patterns rather than patient ineligibility, prompting patients to seek surgeons skilled in this method.
  • Summary: If direct-to-implant is not offered, it may be due to the surgeon adhering to an older school of thought, as younger surgeons are more likely to utilize this technique. Data suggests only 11% of institutions nationwide perform direct-to-implant procedures, leading to high revision rates (up to 50%) when patients default to older methods. Patients should ask surgeons about their rates for direct-to-implant and nipple-sparing mastectomies.
Nipple Sensation Preservation
Copied to clipboard!
(01:17:10)
  • Key Takeaway: Mastectomy inherently causes loss of sensation in the breast skin and nipples, a fact often undisclosed, but resensation techniques using nerve grafts can potentially restore feeling over one to two years.
  • Summary: Loss of sensation is a common, often unmentioned, consequence of mastectomy, which can lead to physical dangers like unnoticed burns from heating pads or curling irons. Resensation involves finding the nerve stump leading to the nipple, cutting it, and connecting it to a cadaveric nerve graft, allowing the nerve to ‘find its soulmate’ and potentially regain function. Insurance often covers the nerve graft, and this procedure takes only about 15 extra minutes during surgery.
Nipple Sparing Margins
Copied to clipboard!
(01:38:29)
  • Key Takeaway: Nipples should be treated as ‘innocent until proven guilty,’ meaning they should be preserved during mastectomy unless post-operative pathology confirms cancer cells have infiltrated the tissue closest to the nipple (margins).
  • Summary: Preemptive nipple removal based on imaging suggesting proximity to cancer is often unnecessary, as not all suspicious findings on MRI are malignant; for example, lactation changes can mimic cancer. The surgeon waits for pathology results after the case to confirm clean margins before deciding to keep the nipple, avoiding unnecessary removal. This approach is contrasted with the common location of breast cancer, which is usually not near the nipple.
Lymph Node Biopsy for DCIS
Copied to clipboard!
(01:42:28)
  • Key Takeaway: For DCIS (Stage 0 cancer) undergoing mastectomy, sentinel lymph node biopsy should be avoided unless invasive cancer is confirmed, utilizing techniques like Magtrace to map nodes for potential delayed sampling.
  • Summary: DCIS has a very low likelihood of spreading systemically, meaning lymph node sampling is often unnecessary and carries a 5% risk of permanent lymphedema. Magtrace is an in-operating room injection that tags the lowest lymph node, allowing surgeons to sample only if invasive cancer is later found, saving 95% of women from unnecessary lymph node removal. Lymph nodes should be considered ‘innocent until proven guilty’ in DCIS cases.